Dr. Bruce D. Forrest Joins Skymount Medical as Chief Medical Officer, Strengthening Team for Future Growth

Bruce D. Forrest, MD, MBA brings over 30 years of global leadership in pharmaceutical development June 22, 2022 10:15 ET | Source: Skymount Medical, Inc. CALGARY, Alberta and NEW ORLEANS, June 22, 2022 (GLOBE NEWSWIRE) — Skymount Medical, a drug … Read More

The Best Time to Plant A Tree Was Twenty Years Ago

May 31, 2022 | Source: Business in Edmonton It is hard to keep up with all of the incredible things going on in Alberta these days. One of the shining lights is the development of our expertise in Artificial intelligence … Read More

Skymount Medical Wins Silver Stevie® Award for Its LSU-Developed DeepDrug™ Artificial Intelligence Platform to Accelerate Drug Discovery

CALGARY, AB and BATON ROUGE, La.— May 31, 2022 — Skymount Medical, a drug discovery company using an artificial intelligence (AI) platform developed by Louisiana State University (LSU) researchers to repurpose and build new drugs for innovative new therapies, announced … Read More

Skymount Medical Receives UK MHRA Approval to Test New Treatment in Patients with Mild to Moderate COVID-19

— MHRA grants permission for UK clinical trials for AI-discovered drug combination that reduces length and severity of symptoms and could lower hospitalizations — — Approval expands Skymount Medical’s global reach — CALGARY, Alberta and BATON ROGUE, La., Feb. 22, … Read More

Riverside University Health System Medical Center, Skymount Medical Begin U.S. Clinical Trial for COVID-19 Oral Therapeutics Discovered Using Artificial Intelligence

CALGARY, AB and MORENO VALLEY, Calif. and BATON ROUGE, La., Nov. 3, 2021 /PRNewswire/ — Skymount Medical has partnered with Riverside University Health System (RUHS) Medical Center to conduct the first U.S. clinical trial on the efficacy of COVID-19 oral … Read More